BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 1543952)

  • 1. Transmission of toxoplasmosis by bone marrow transplant associated with Campath-1G.
    Jurges E; Young Y; Eltumi M; Holliman RE; Vellodi A; Rogers TR; Hobbs JR
    Bone Marrow Transplant; 1992 Jan; 9(1):65-6. PubMed ID: 1543952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Failure of purged autologous bone marrow transplantation in high risk acute lymphoblastic leukaemia in first complete remission.
    Gilmore MJ; Hamon MD; Prentice HG; Katz F; Slaper-Cortenbach IC; Hunter AE; Gandhi L; Brenner MK; Hoffbrand AV; Mehta AB
    Bone Marrow Transplant; 1991 Jul; 8(1):19-26. PubMed ID: 1717092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Graft rejection by a population of primed CDw52- host T cells after in vivo/ex vivo T-depleted bone marrow transplantation.
    Bunjes D; Theobald M; Wiesneth M; Schrezenmeier H; Hoffmann T; Hertenstein B; Arnold R; Heimpel H
    Bone Marrow Transplant; 1993 Sep; 12(3):209-15. PubMed ID: 8241978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T cell-depleted allogeneic bone marrow transplantation from a partially HLA-mismatched unrelated donor for progressive chronic lymphocytic leukemia and fludarabine-induced bone marrow failure.
    Mehta J; Powles R; Singhal S; Matthey F; Hamblin M; Middleton G; Prendiville J; Glynne P; Zomas A; Treleaven J; Catovsky D
    Bone Marrow Transplant; 1996 May; 17(5):881-3. PubMed ID: 8733715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.
    Soiffer RJ; Mauch P; Fairclough D; Alyea E; Anderson K; Fisher D; Freedman A; Bartlett-Pandite L; Robertson M; Schlossman R; Gollob J; Marcus K; Murray C; Kuhlman C; Freeman A; Nadler L; Ritz J
    Biol Blood Marrow Transplant; 1997 Apr; 3(1):11-7. PubMed ID: 9209736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Graft-versus-leukemia in bone marrow transplantation. The Advisory Committee of the International Bone Marrow Transplant Registry.
    Gale RP; Horowitz MM
    Bone Marrow Transplant; 1990 Jul; 6 Suppl 1():94-7. PubMed ID: 2390646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Acute lymphoblastic leukemia in childhood treated with non-T-cell depleted bone marrow transplantation from an HLA 2 loci (HLA-A and-DRB1)-mismatched mother after early graft failure of cord blood transplantation].
    Ishida H; Mori K; Yoshihara T; Shin N; Morimoto A; Imashuku S
    Rinsho Ketsueki; 2003 Nov; 44(11):1101-6. PubMed ID: 14689875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allogeneic matched T-cell-depleted bone marrow transplantation for acute leukemia patients.
    Aristei C; Aversa F; Raymondi C; Marsella AR; Panizza BM; Perrucci E; Piro F; Maranzano E; Lupattelli M; Martelli MF; Latini P
    Cancer J Sci Am; 1996; 2(6):330-4. PubMed ID: 9166553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Allogeneic bone marrow transplantation in a case of acute lymphoblastic leukemia with positive Philadelphia chromosome].
    Kitoh T; Tabata Y; Akiyama Y; Kiriyama Y; Kubota M; Mikawa H
    Rinsho Ketsueki; 1989 May; 30(5):680-5. PubMed ID: 2795882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allogeneic cell-mediated immunotherapy using donor lymphocytes for prevention of relapse in patients treated with allogeneic bone marrow transplantation for hematological malignancies.
    Naparstek E; Nagler A; Or R; Kapelushnik J; Slavin S
    Clin Transpl; 1996; ():281-90. PubMed ID: 9286578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Allogenic bone marrow transplantation versus autograft in acute lymphoblastic leukemia, in second remission in 113 children. Results of the Grupo Español de Transplante de Medula Niños (GETMON)].
    Badell I; Ortega JJ; Muñoz A; Bureo E; Madero L; Olivé T; Cubells J; Maldonado MS; Baro J; Díaz MA
    Sangre (Barc); 1996 Apr; 41(2):101-8. PubMed ID: 9045349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. XomaZyme-CD5 immunotoxin in conjunction with partial T cell depletion for prevention of graft rejection and graft-versus-host disease after bone marrow transplantation from matched unrelated donors.
    Koehler M; Hurwitz CA; Krance RA; Coustan-Smith E; Williams LL; Santana V; Ribeiro RC; Brenner MK; Heslop HE
    Bone Marrow Transplant; 1994 May; 13(5):571-5. PubMed ID: 7519937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. One antigen mismatched related donor bone marrow transplant in a patient with acute lymphoblastic leukaemia and beta-thalassaemia major: potential cure of both marrow disorders.
    Kottaridis PD; Peggs K; Lawrence A; Verfuerth S; Chatterjee R; Telfer P; Porter JB; Mackinnon S; Goldstone AH
    Bone Marrow Transplant; 2000 Mar; 25(6):677-8. PubMed ID: 10734304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune response of post-transplant peripheral lymphocytes against the patient pre-B cell line, NAGL-1.
    Kasai M; Akatsuka Y; Emi N; Taji H; Kohno A; Abe A; Tanimoto M; Kodera Y; Saito H
    Int J Hematol; 1999 Feb; 69(2):112-8. PubMed ID: 10071461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allogeneic transplantation of blood-derived, T cell-depleted hemopoietic stem cells after myeloablative treatment in a patient with acute lymphoblastic leukemia.
    Kessinger A; Smith DM; Strandjord SE; Landmark JD; Dooley DC; Law P; Coccia PF; Warkentin PI; Weisenburger DD; Armitage JO
    Bone Marrow Transplant; 1989 Nov; 4(6):643-6. PubMed ID: 2573397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Celiac disease transmitted by allogeneic non-T cell-depleted bone marrow transplantation.
    Bargetzi MJ; Schönenberger A; Tichelli A; Fried R; Cathomas G; Signer E; Speck B; Gratwohl A
    Bone Marrow Transplant; 1997 Oct; 20(7):607-9. PubMed ID: 9337064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Successful donor lymphocyte infusion for Epstein-Barr virus-associated lymphoproliferative disorder after allogeneic bone marrow transplantation from an HLA 1-locus-mismatched sibling donor in a patient with acute lymphocytic leukemia].
    Yago K; Itoh M; Shimada H
    Rinsho Ketsueki; 2001 Nov; 42(11):1105-10. PubMed ID: 11808079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytotoxic and proliferative functions of T lymphocyte clones derived very shortly after allogeneic bone marrow transplantation.
    Hamann W; Bruserud O; Patel S; Schmidt H; Ehninger G; Pawelec G
    Bone Marrow Transplant; 1991 Aug; 8(2):113-8. PubMed ID: 1933051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disseminated toxoplasmosis in marrow recipients: a report of three cases and a review of the literature. Bone Marrow Transplant Team.
    Chandrasekar PH; Momin F
    Bone Marrow Transplant; 1997 Apr; 19(7):685-9. PubMed ID: 9156245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute graft-versus-host disease after bone marrow transplantation with a single HLA-DPB1*1001 mismatch: involvement of different TCRBV subsets.
    Gaschet J; Gallot G; Ibisch C; Lim A; Even J; Vivien R; Hallet MM; Milpied N; Vié H
    Bone Marrow Transplant; 1998 Aug; 22(4):385-92. PubMed ID: 9722075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.